Oric Pharmaceuticals, Inc. 8-K

What Happened
Oric Pharmaceuticals, Inc. announced its financial results for the fiscal quarter ended March 31, 2026 in a press release dated May 4, 2026. The company furnished that press release as Exhibit 99.1 to an 8-K under Item 2.02 (Results of Operations and Financial Condition). The filing does not itself include detailed financial figures; investors should consult the attached press release for revenue, earnings and other quarterly results.

Key Details

• Press release announcing quarter results was issued and furnished on May 4, 2026.
• The results cover the fiscal quarter ended March 31, 2026.
• The press release is attached to the 8-K as Exhibit 99.1.
• The filing states the exhibit is “furnished” (Item 9.01) and not deemed “filed” for purposes of Section 18 of the Exchange Act or incorporated by reference in other filings.

Why It Matters
This 8-K signals that Oric has publicly reported its latest quarterly financial results; those numbers (revenue, net income/loss, cash position, guidance, etc.) will be in the press release and matter for short-term valuation and investor decisions. The statement that the release is furnished—not filed—affects legal liability and how the content may be used in subsequent SEC filings. Investors should read Exhibit 99.1 for the specific earnings and financial details.